
No data
No data
No data
| CAS Number | 10118-90-8 |
| Catalog Number | AG00H9G0(AGN-PC-0OQE2X) |
| Chemical Name | (4S,4As,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide dihydrochloride |
| IUPAC Name | (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide |
| InChI | InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1 |
| InChI Key | FFTVPQUHLQBXQZ-KVUCHLLUSA-N |
| MDL Number | MFCD00072105 |
| Molecular Formula | C23H27N3O7 |
| Molecular Weight | 457.4764 |
| SMILES | O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N |
| UNII | FYY3R43WGO |
| Synonyms | Akamin,
Akne Puren,
Akne-Puren,
Aknemin,
Aknin Mino,
Aknin-Mino,
Aknosan,
Apo Minocycline,
Apo-Minocycline,
Arestin,
Blemix,
Cyclomin,
Cyclops,
Dentomycin,
Dynacin,
Hydrochloride, Minocycline,
Icht Oral,
Icht-Oral,
Klinomycin,
Lederderm,
Mestacine,
Minakne,
Mino Wolff,
Mino-Wolff,
Minocin,
Minocin MR,
Minoclir,
Minocycline,
Minocycline Hydrochloride,
Minocycline Monohydrochloride,
Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,
Minolis,
Minomycin,
Minoplus,
Minotab,
Minox 50,
Monohydrochloride, Minocycline,
Mynocine,
minocycline,
10118-90-8,
Minocyclin,
Minociclina,
Minocyclinum,
Minocyn,
Dynacin,
Minocin,
Minomycin,
Minocyclinum [INN-Latin],
Minociclina [INN-Spanish],
7-Dimethylamino-6-demethyl-6-deoxytetracycline,
UNII-FYY3R43WGO,
CL 59806,
Klinomycin,
Tri-minocycline,
CHEBI:50694,
HSDB 3130,
FYY3R43WGO,
MINO,
BRN 3077644,
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE,
C23H27N3O7,
Solodyn,
Vectrin,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-,
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide,
NCGC00183044-01,
Borymycin,
MIY,
minociclinum,
Aknemin,
Minocline,
Akamin,
Minoz,
Apo-Minocycline,
Minocycline Monohydrochloride,
(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide,
Minocycline [USAN:BAN:INN],
Minocin (Hydrochloride),
Vectrin (Hydrochloride),
Minocycline (USAN/INN),
Lactoferrin B & Minocycline,
Lactoferrin H & Minocycline,
Minoderm,
Sebomin,
Gen-Minocycline,
Minocycline [USAN:INN:BAN],
SR-05000001675,
(minocycline),
Alti-Minocycline,
Novo-Minocycline,
Mino-Tabs,
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide,
AC1NQXWM,
NSC141993,
Spectrum_000967,
AC1L2NSN,
AC1NSG0A,
Prestwick0_000315,
Prestwick1_000315,
Prestwick2_000315,
Spectrum2_001047,
Spectrum3_000508,
Spectrum4_000062,
Spectrum5_001293,
SCHEMBL4042,
CHEMBL1434,
DSSTox_CID_25033,
DSSTox_RID_80650,
DSSTox_GSID_45033,
SCHEMBL24315,
BSPBio_002035,
KBioGR_000583,
KBioSS_001447,
ls-007,
DivK1c_000450,
SPBio_000974,
SPBio_002529,
CHEMBL259172,
DTXSID1045033,
SCHEMBL16681149,
BCBcMAP01_000027,
KBio1_000450,
KBio2_001447,
KBio2_004015,
KBio2_006583,
KBio3_001535,
DYKFCLLONBREIL-KVUCHLLUSA-N,
NINDS_000450,
HMS2090D03,
KUC106429N,
KSC-12-231B,
ZINC4019704,
Tox21_113643,
BDBM50103599,
LMPK07000002,
ZINC14879992,
AKOS015969674,
ZINC100409820,
API0003397,
BCP9000928,
DB01017,
IDI1_000450,
SMP1_000191,
NCGC00178854-01,
NCGC00188954-01,
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione,
AC-30184,
AJ-65483,
LS-93850,
SBI-0051449.P003,
CAS-10118-90-8,
AM20090714,
FT-0628949,
1371-EP2269978A2,
1371-EP2269985A2,
1371-EP2269991A2,
1371-EP2272832A1,
1371-EP2284150A2,
1371-EP2284151A2,
1371-EP2284152A2,
1371-EP2284153A2,
1371-EP2284155A2,
1371-EP2284156A2,
1371-EP2284164A2,
1371-EP2287140A2,
1371-EP2287148A2,
1371-EP2287150A2,
1371-EP2289871A1,
1371-EP2292590A2,
1371-EP2292612A2,
1371-EP2295402A2,
1371-EP2295419A2,
1371-EP2295426A1,
1371-EP2295427A1,
1371-EP2298732A1,
1371-EP2301534A1,
1371-EP2301912A2,
1371-EP2301913A1,
1371-EP2301914A1,
1371-EP2301916A2,
1371-EP2305637A2,
1371-EP2308832A1,
1371-EP2308863A1,
1371-EP2311451A1,
1371-EP2311796A1,
1371-EP2311797A1,
1371-EP2311798A1,
1371-EP2311799A1,
1371-EP2316450A1,
18M908,
C07225,
D05045,
AB00053501-03,
AB00053501_04,
AB00053501_05,
J-500789,
SR-05000001675-3,
(2E,4S,4aR,5aS,12aR)-2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3 ,12-trione,
(2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione,
(4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione,
Arestin,
Minocycline HCl,
Dentomycin,
Cyclomin,
Lederderm,
Mestacine,
Minoclir,
Minoplus,
Mynocine,
Aknosan,
Cyclops,
Minakne,
Minolis,
Minotab,
Blemix,
Apo Minocycline,
Akne Puren,
Akne-Puren,
Aknin Mino,
Aknin-Mino,
Mino Wolff,
Mino-Wolff,
Icht Oral,
Icht-Oral,
Minocin MR,
Minocin (TN),
Minox 50,
MINOCYCLINE HYDROCHLORIDE,
Hydrochloride, Minocycline,
D08LTU,
CRL-1605 & Minocycline,
cc-666,
Monohydrochloride, Minocycline,
NSC 141993,
C23-H27-N3-O7,
ACN-034473,
CID5281021,
CID5362502,
2006B,
D008911,
Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,
13614-98-7,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,12a.alpha.)]-,
|
| Complexity | 971 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 457.185g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 33 |
| Hydrogen Bond Acceptor Count | 9 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 457.483g/mol |
| Monoisotopic Mass | 457.185g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 165A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.6 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H302-H319-H361 |
| Packing Group | Ⅲ |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

